# Aaon, Inc.: financial statements, quarterly

AAON · Nasdaq · CIK 824142 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aaon.md) · [Financials](/companies/aaon/financials.md) · [Filings](/companies/aaon/filings.md) · [Insiders](/companies/aaon/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aaon/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [312](/filings/0000824142-24-000211.md) | [307 d](/filings/0000824142-26-000005.md) | [262](/filings/0000824142-25-000120.md) | [314](/filings/0000824142-25-000183.md) | [327](/filings/0000824142-25-000199.md) | [298 d](/filings/0000824142-26-000005.md) | [322](/filings/0000824142-26-000036.md) | [312](/filings/0000824142-26-000055.md) | [384](/filings/0000824142-25-000199.md) | [424 d](/filings/0000824142-26-000005.md) | [497](/filings/0000824142-26-000036.md) | [627](/filings/0000824142-26-000055.md) |
| Cost of revenue | $m | [196](/filings/0000824142-24-000211.md) | [195 d](/filings/0000824142-26-000005.md) | [170](/filings/0000824142-25-000120.md) | [200](/filings/0000824142-25-000183.md) | [213](/filings/0000824142-25-000199.md) | [220 d](/filings/0000824142-26-000005.md) | [236](/filings/0000824142-26-000036.md) | [229](/filings/0000824142-26-000055.md) | [277](/filings/0000824142-25-000199.md) | [314 d](/filings/0000824142-26-000005.md) | [372](/filings/0000824142-26-000036.md) | [474](/filings/0000824142-26-000055.md) |
| Gross profit | $m | [116](/filings/0000824142-24-000211.md) | [112 d](/filings/0000824142-26-000005.md) | [92.2](/filings/0000824142-25-000120.md) | [113](/filings/0000824142-25-000183.md) | [114](/filings/0000824142-25-000199.md) | [77.6 d](/filings/0000824142-26-000005.md) | [86.4](/filings/0000824142-26-000036.md) | [82.7](/filings/0000824142-26-000055.md) | [107](/filings/0000824142-25-000199.md) | [110 d](/filings/0000824142-26-000005.md) | [125](/filings/0000824142-26-000036.md) | [152](/filings/0000824142-26-000055.md) |
| Selling, general and administrative | $m | [51.5](/filings/0000824142-24-000211.md) | [47.9 d](/filings/0000824142-26-000005.md) | [45.3](/filings/0000824142-25-000120.md) | [45.9](/filings/0000824142-25-000183.md) | [48.6](/filings/0000824142-25-000199.md) | [48.2 d](/filings/0000824142-26-000005.md) | [51.3](/filings/0000824142-26-000036.md) | [59.1](/filings/0000824142-26-000055.md) | [63.2](/filings/0000824142-25-000199.md) | [65.8 d](/filings/0000824142-26-000005.md) | [67.9](/filings/0000824142-26-000036.md) | [83.6](/filings/0000824142-26-000055.md) |
| Operating income | $m | [64.7](/filings/0000824142-24-000211.md) | [63.9 d](/filings/0000824142-26-000005.md) | [47.0](/filings/0000824142-25-000120.md) | [67.2](/filings/0000824142-25-000183.md) | [65.5](/filings/0000824142-25-000199.md) | [29.4 d](/filings/0000824142-26-000005.md) | [35.1](/filings/0000824142-26-000036.md) | [23.6](/filings/0000824142-26-000055.md) | [43.6](/filings/0000824142-25-000199.md) | [44.0 d](/filings/0000824142-26-000005.md) | [57.1](/filings/0000824142-26-000036.md) | [68.9](/filings/0000824142-26-000055.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [15.4](/filings/0000824142-24-000211.md) | [16.1 d](/filings/0000824142-26-000005.md) | [7.8](/filings/0000824142-25-000120.md) | [14.8](/filings/0000824142-25-000183.md) | [11.9](/filings/0000824142-25-000199.md) | [3.6 d](/filings/0000824142-26-000005.md) | [3.2](/filings/0000824142-26-000036.md) | [4.0](/filings/0000824142-26-000055.md) | [7.7](/filings/0000824142-25-000199.md) | [6.3 d](/filings/0000824142-26-000005.md) | [12.3](/filings/0000824142-26-000036.md) | [6.2](/filings/0000824142-26-000055.md) |
| Net income | $m | [48.1](/filings/0000824142-24-000211.md) | [47.0 d](/filings/0000824142-26-000005.md) | [39.0](/filings/0000824142-25-000120.md) | [52.2](/filings/0000824142-25-000183.md) | [52.6](/filings/0000824142-25-000199.md) | [24.7 d](/filings/0000824142-26-000005.md) | [29.3](/filings/0000824142-26-000036.md) | [15.5](/filings/0000824142-26-000055.md) | [30.8](/filings/0000824142-25-000199.md) | [32.0 d](/filings/0000824142-26-000005.md) | [39.8](/filings/0000824142-26-000036.md) | [56.7](/filings/0000824142-26-000055.md) |
| Diluted EPS | $ per share | [0.58](/filings/0000824142-24-000211.md) | not reported | [0.46](/filings/0000824142-25-000120.md) | [0.62](/filings/0000824142-25-000183.md) | [0.63](/filings/0000824142-25-000199.md) | not reported | [0.35](/filings/0000824142-26-000036.md) | [0.19](/filings/0000824142-26-000055.md) | [0.37](/filings/0000824142-25-000199.md) | not reported | [0.48](/filings/0000824142-26-000036.md) | [0.68](/filings/0000824142-26-000055.md) |
| Basic EPS | $ per share | [0.59](/filings/0000824142-24-000211.md) | not reported | [0.48](/filings/0000824142-25-000120.md) | [0.64](/filings/0000824142-25-000183.md) | [0.65](/filings/0000824142-25-000199.md) | not reported | [0.36](/filings/0000824142-26-000036.md) | [0.19](/filings/0000824142-26-000055.md) | [0.38](/filings/0000824142-25-000199.md) | not reported | [0.49](/filings/0000824142-26-000036.md) | [0.69](/filings/0000824142-26-000055.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.2](/filings/0000824142-23-000174.md) | [0.3](/filings/0000824142-25-000039.md) | [8.4](/filings/0000824142-24-000120.md) | [0.0](/filings/0000824142-24-000187.md) | [0.0](/filings/0000824142-24-000211.md) | [0.0](/filings/0000824142-26-000005.md) | [1.0](/filings/0000824142-25-000120.md) | [0.0](/filings/0000824142-25-000183.md) | [1.0](/filings/0000824142-25-000199.md) | [0.0](/filings/0000824142-26-000055.md) | [0.0](/filings/0000824142-26-000036.md) | [0.0](/filings/0000824142-26-000055.md) |
| Current assets | $m | [425](/filings/0000824142-23-000174.md) | [409](/filings/0000824142-25-000039.md) | [392](/filings/0000824142-24-000120.md) | [423](/filings/0000824142-24-000187.md) | [428](/filings/0000824142-24-000211.md) | [488](/filings/0000824142-26-000005.md) | [572](/filings/0000824142-25-000120.md) | [654](/filings/0000824142-25-000183.md) | [759](/filings/0000824142-25-000199.md) | [869](/filings/0000824142-26-000055.md) | [944](/filings/0000824142-26-000036.md) | [995](/filings/0000824142-26-000055.md) |
| Total assets | $m | [945](/filings/0000824142-23-000174.md) | [941](/filings/0000824142-25-000039.md) | [953](/filings/0000824142-24-000120.md) | [1,011](/filings/0000824142-24-000187.md) | [1,031](/filings/0000824142-24-000211.md) | [1,175](/filings/0000824142-26-000005.md) | [1,300](/filings/0000824142-25-000120.md) | [1,399](/filings/0000824142-25-000183.md) | [1,534](/filings/0000824142-25-000199.md) | [1,687](/filings/0000824142-26-000055.md) | [1,790](/filings/0000824142-26-000036.md) | [1,864](/filings/0000824142-26-000055.md) |
| Current liabilities | $m | [140](/filings/0000824142-23-000174.md) | [127](/filings/0000824142-25-000039.md) | [125](/filings/0000824142-24-000120.md) | [141](/filings/0000824142-24-000187.md) | [140](/filings/0000824142-24-000211.md) | [175](/filings/0000824142-26-000005.md) | [207](/filings/0000824142-25-000120.md) | [211](/filings/0000824142-25-000183.md) | [250](/filings/0000824142-25-000199.md) | [331](/filings/0000824142-26-000055.md) | [360](/filings/0000824142-26-000036.md) | [330](/filings/0000824142-26-000055.md) |
| Current portion of debt | $m | not reported | [0.0](/filings/0000824142-25-000039.md) | not reported | not reported | not reported | [16.0](/filings/0000824142-26-000005.md) | [16.0](/filings/0000824142-25-000120.md) | [0.0](/filings/0000824142-25-000183.md) | [0.0](/filings/0000824142-25-000199.md) | [0.0](/filings/0000824142-26-000005.md) | not reported | not reported |
| Shareholders' equity | $m | [682](/filings/0000824142-24-000211.md) | [735](/filings/0000824142-26-000005.md) | [785](/filings/0000824142-25-000183.md) | [740](/filings/0000824142-25-000199.md) | [797](/filings/0000824142-25-000199.md) | [825](/filings/0000824142-26-000055.md) | [816](/filings/0000824142-26-000055.md) | [833](/filings/0000824142-26-000055.md) | [863](/filings/0000824142-25-000199.md) | [895](/filings/0000824142-26-000055.md) | [934](/filings/0000824142-26-000055.md) | [1,010](/filings/0000824142-26-000055.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [47.2 d](/filings/0000824142-24-000211.md) | [51.8 d](/filings/0000824142-26-000005.md) | [92.4](/filings/0000824142-25-000120.md) | [35.5 d](/filings/0000824142-25-000183.md) | [63.8 d](/filings/0000824142-25-000199.md) | [0.8 d](/filings/0000824142-26-000005.md) | [(9.2)](/filings/0000824142-26-000036.md) | [(21.8) d](/filings/0000824142-26-000055.md) | [12.3 d](/filings/0000824142-25-000199.md) | [19.3 d](/filings/0000824142-26-000005.md) | [34.0](/filings/0000824142-26-000036.md) | [21.0 d](/filings/0000824142-26-000055.md) |
| Capital expenditure | $m | [22.3 d](/filings/0000824142-23-000174.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [6.9 d](/filings/0000824142-24-000211.md) | [6.5 d](/filings/0000824142-26-000005.md) | [6.6](/filings/0000824142-25-000120.md) | [6.5 d](/filings/0000824142-25-000183.md) | [6.5 d](/filings/0000824142-25-000199.md) | [6.5 d](/filings/0000824142-26-000005.md) | [8.1](/filings/0000824142-26-000036.md) | [8.2 d](/filings/0000824142-26-000055.md) | [8.2 d](/filings/0000824142-25-000199.md) | [8.2 d](/filings/0000824142-26-000005.md) | [8.1](/filings/0000824142-26-000036.md) | [8.2 d](/filings/0000824142-26-000055.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends, us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [80.9](/filings/0000824142-23-000174.md) | [82.9](/filings/0000824142-24-000120.md) | [83.5](/filings/0000824142-24-000187.md) | [83.4](/filings/0000824142-24-000211.md) | [84.0](/filings/0000824142-25-000120.md) | [83.8](/filings/0000824142-25-000183.md) | [83.1](/filings/0000824142-25-000199.md) | [83.4](/filings/0000824142-26-000036.md) | [83.0](/filings/0000824142-26-000055.md) | [83.0](/filings/0000824142-25-000199.md) | [83.2](/filings/0000824142-26-000036.md) | [83.7](/filings/0000824142-26-000055.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 82,453,639 at 2026-08-06, from the cover of the [10-Q filed 2026-08-10](/filings/0000824142-26-000055.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.